NEXSPIKE becomes Moderna’s third FDA-approved product CAMBRIDGE, MA / ACCESS Newswire / May 31, 2025 / Moderna, Inc.

The Key Phrase Investors Should Watch Elon Musk’s tendency to set ambitious deadlines that often go unmet has become a ...

Kanye West isn't feeling Kid Cudi testifying in the Diddy trial. Hitting X, Ye wrote: “I wish Cudi hadn’t testified against Puff.” ...

I've been using the Razer Joro for a few weeks, and it's now my go-to keyboard for when I need to leave the house... But it's ...

SZA's promotional appearance in Phoenix, Arizona, took an unfortunate turn on May 28 when an audience member hurled a ...

Nicola Thorp opens up about stakler ordeal ” embed=”in-page” experience_id=”” height=”100%” language_detection=”” ...

After the chairman of the Federal Reserve, Jerome Powell, met with Donald Trump at the White House Thursday, the bank took ...

Mahmoud Khalil, the Columbia University graduate and pro-Palestine activist detained by the Trump administration and ...

Detailed price information for Cathedra Bitcoin Inc (CBIT-X) from The Globe and Mail including charting and trades.

It's more accurate to say that about 8 million people may lose Medicaid coverage if the "One Big Beautiful Bill Act" becomes law.

The father of the dominant theory of Alzheimer’s disease told another eminent researcher he is “causing harm” by criticizing his theory ...

NurExone expects to initiate a Phase 1/2a clinical trial in 2026 (“ 2026 SCI Trial ”) marking a major milestone in the advancement of regenerative therapies for central nervous system injuries.